Industry Research Reports

Home > Reports > Medical Devices & Consumables > Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published Date: 2026-08-15

Pages: 147 Pages

Report ld: 5506107

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Industry Insights:

Organ-On-Chip Research:CAGR of 31.2% during the forecast period

Organ On Chip Market Size(US$)

CAGR 2026-2032

30.2%

Market Size,2032

USD 1,368

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 281 million

Market Forecast in 2032(Value)

US$ 1,368 million

CAGR

30.2%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Organ On Chip was estimated to be worth US$ 221 million in 2025 and is projected to reach US$ 1368 million, growing at a CAGR of 30.2% from 2026 to 2032.

A Organ on Chip is a small-scale device that replicates the mechanical and biological properties of human organs. These chips contain tiny channels lined with living human cells that form tissue layers. They can simulate the physiology of various organs, such as the heart, liver, lungs, kidneys, and intestines, allowing researchers to better understand organ-specific functions and diseases. These models are typically made using microfluidic technology, where human cells are cultured in a small, transparent chip, allowing researchers to simulate organ-specific functions and study disease processes, drug responses, and more. By offering more accurate, scalable, and human-relevant data, Human Organs-on-Chips are revolutionizing biomedical research and drug testing, providing a bridge between traditional animal models and human clinical trials.The price of Organ-on-Chip products varies significantly depending on chip architecture, number of microfluidic channels, integration of perfusion or sensing functions, and automation level. In 2025–2026, basic microfluidic organ-on-chip devices are generally priced at around US$20–100 per chip, while multi-well or high-throughput chip plates are typically about US$80–500 per plate. Supporting pumps, controllers, and culture modules usually cost approximately US$3,000–20,000 per system, while fully integrated and automated organ-on-chip platforms may exceed US$20,000–100,000 per system.

The upstream value chain mainly includes chip substrate materials such as PDMS, COP/COC, and glass, together with porous membranes, ECM/hydrogels, cells, culture media, sensors, and microfluidic components. Midstream companies such as Emulate, MIMETAS, TissUse, CN Bio, and AIM Biotech are responsible for microfluidic chip design, manufacturing, and integration of culture and perfusion systems. Downstream users mainly include pharmaceutical and biotechnology companies, CROs, academic and research institutions, and regulatory science organizations. Organ-on-chip platforms are primarily used for drug screening, ADME/DMPK studies, toxicology assessment, disease modeling, precision medicine, and the reduction or replacement of animal testing.

Market Drivers

Regulatory Support for Reducing Animal Testing

Global drug development regulations are increasingly encouraging the adoption of non-animal testing methods. Organ-on-chip systems can use human-derived cells to reproduce organ-specific microenvironments and physiological functions, offering stronger human relevance for drug safety, toxicology, and efficacy assessment. Continued support from regulatory and research organizations such as the FDA, NIH, and European institutions is accelerating the adoption and commercialization of microphysiological systems and organ-on-chip technologies.

Growing Demand to Improve Pharmaceutical R&D Efficiency

Traditional two-dimensional cell cultures and animal models have limitations in predicting human drug responses. Organ-on-chip platforms combine three-dimensional cell culture, microfluidics, dynamic perfusion, and multicellular co-culture to better reproduce human tissue environments. As drug development costs continue to rise, pharmaceutical companies are increasingly using organ-on-chip systems for candidate screening, ADME/DMPK studies, toxicity testing, and disease modeling.

Increasing Demand for Precision Medicine and Human-Relevant Disease Models

Organ-on-chip technologies can be integrated with patient-derived cells, induced pluripotent stem cells, organoids, and gene-editing technologies to create human-relevant models with specific genetic and disease characteristics. Growing demand for precision treatment in oncology, neurological disorders, rare diseases, and metabolic diseases is expanding the application of organ-on-chip systems in personalized drug screening, disease mechanism research, and patient stratification.

Market Restraints

Relatively High Equipment and Experimental Costs

Organ-on-chip experiments often require microfluidic chips, specialized culture media, extracellular matrices, hydrogels, pumping systems, sensors, and imaging equipment. Overall experimental costs are generally higher than conventional two-dimensional cell culture and standard microplate assays. Integrated and automated organ-on-chip platforms also require relatively high initial capital investment, which can limit adoption among small laboratories and research institutions with restricted budgets.

Limited Standardization Across Platforms

Organ-on-chip manufacturers use different chip materials, channel geometries, membranes, cell sources, culture conditions, flow rates, and analytical methods. The industry has not yet established fully standardized technical specifications and evaluation systems. Differences among platforms may reduce inter-laboratory reproducibility and data comparability, creating barriers to broader adoption in standardized pharmaceutical development and regulatory assessment.

Constraints in High-Quality Cell Sources and Long-Term Culture

The performance of organ-on-chip systems strongly depends on the quality of primary cells, stem-cell-derived cells, and other human-derived biological materials. Some organ-specific cell types remain difficult to obtain and may exhibit batch-to-batch variability, phenotype instability, or limited long-term viability. Variability in cellular materials can directly affect experimental consistency and complicate large-scale deployment and standardized validation.Market Opportunities

Expanding Applications in Drug Safety and Toxicology Assessment

Organ-on-chip platforms have significant potential in drug-induced liver injury, cardiotoxicity, nephrotoxicity, pulmonary toxicity, and blood-brain barrier studies. As regulatory authorities gradually increase acceptance of human-relevant alternative models, organ-on-chip systems are expected to move beyond academic research and become increasingly integrated into preclinical safety assessment workflows, creating strong opportunities for liver-on-chip, heart-on-chip, kidney-on-chip, and related platforms.

Development of High-Throughput and Automated Platforms

The industry is moving from individual microfluidic devices toward multi-well-compatible, high-throughput, and automated systems. These platforms are increasingly integrated with automated liquid handling, high-content imaging, real-time biosensors, and AI-based data analysis. High-throughput systems can reduce per-test costs, improve reproducibility, and facilitate integration into existing pharmaceutical screening workflows, supporting growth in both consumable chips and supporting instruments.

Strong Potential for Multi-Organ and Body-on-Chip Systems

Multi-organ platforms can connect liver, intestine, kidney, heart, and other tissue models to investigate drug absorption, distribution, metabolism, excretion, and organ-to-organ interactions. As microfluidic control, long-term culture, and multi-organ coupling technologies continue to improve, these systems are expected to gain wider use in systemic toxicology, PK/PD analysis, and complex disease modeling, creating new high-value market segments.

Market Challenges

Balancing Physiological Relevance with Throughput

Organ-on-chip systems rely on multicellular co-culture, three-dimensional extracellular matrices, mechanical stimulation, dynamic fluid flow, and sensing technologies to improve physiological relevance. However, greater biological complexity generally increases manufacturing costs, operational difficulty, and experimental failure risks. Achieving an effective balance among model complexity, reproducibility, throughput, cost, and ease of use remains a major technical challenge for large-scale commercialization.

Regulatory Acceptance Requires Extensive Validation

Although regulatory authorities are showing increasing interest in organ-on-chip and microphysiological systems, replacing conventional animal testing or using these platforms for formal regulatory decision-making still requires extensive inter-laboratory validation, reference-compound testing, and comparison with clinical data. Different organ models may progress through validation and regulatory acceptance at different speeds, potentially slowing commercial adoption.

Competition Among Multiple Technology Platforms

The market includes membrane-based, membrane-free, ECM-based microfluidic, multi-well plate, pump-driven, and gravity-driven organ-on-chip architectures. Each platform has different advantages in physiological relevance, throughput, operational complexity, and cost. Uncertainty over which technologies will ultimately become widely accepted by pharmaceutical companies and regulatory authorities increases R&D risks for manufacturers and platform-selection risks for customers.

MARKET SEGMENTATION

By Company

Emulate
MIMETAS
TissUse
CN Bio Innovations
AIM Biotech
AlveoliX
Beonchip
React4life
InSphero
NETRI
SynVivo
BiomimX
Dynamic42
Kirkstall
Cherry Biotech
Micronit
Cellbox Labs
REVIVO BioSystems
MesoBioTech
Beijing Daxiang Biotech
AVATARGET
Suzhou Jiyan Biopharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs

Segment by Application

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others

Segment by Category

Single-organ-on-Chip
Multi-organ-on-Chip

Segment by Division

Membrane-based Organ-on-Chip
Membrane-free Organ-on-Chip

biaoTi REPORT SCOPE

This report provides a comprehensive view of the global market for Organ On Chip, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by End User.

The Organ On Chip market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Organ On Chip.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Organ On Chip companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by End User, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Organ On Chip revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Organ On Chip revenue at the country level. It provides segmented data by Type and by End User for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Organ On Chip Product Introduction

1.2 Global Organ On Chip Market Size Forecast (2021–2032)

1.3 Organ On Chip Market Trends & Drivers

1.3.1 Organ On Chip Industry Trends

1.3.2 Organ On Chip Market Drivers & Opportunities

1.3.3 Organ On Chip Market Challenges

1.3.4 Organ On Chip Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Organ On Chip Players Revenue Ranking (2025)

2.2 Global Organ On Chip Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Organ On Chip Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Organ On Chip

2.6 Organ On Chip Market Competitive Analysis

2.6.1 Organ On Chip Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Organ On Chip Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Organ On Chip revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Organ On Chip Market Classification

3.1 Introduction by Type

3.1.1 Brain-on-a-chip

3.1.2 Liver-on-a-chip

3.1.3 Kidney-on-a-chip

3.1.4 Lung-on-a-chip

3.1.5 Heart-on-a-chip

3.1.6 Intestine-on-a-chip

3.1.7 Vessel-on-a-chip

3.1.8 Other Organs

3.1.9 Global Organ On Chip Sales Value by Type

3.1.9.1 Global Organ On Chip Sales Value by Type (2021 vs 2025 vs 2032)

3.1.9.2 Global Organ On Chip Sales Value, by Type (2021–2032)

3.1.9.3 Global Organ On Chip Sales Value, by Type (%), 2021–2032

3.2 Introduction by System Integration

3.2.1 Single-organ-on-Chip

3.2.2 Multi-organ-on-Chip

3.2.3 Global Organ On Chip Sales Value by System Integration

3.2.3.1 Global Organ On Chip Sales Value by System Integration (2021 vs 2025 vs 2032)

3.2.3.2 Global Organ On Chip Sales Value, by System Integration (2021–2032)

3.2.3.3 Global Organ On Chip Sales Value, by System Integration (%), 2021–2032

3.3 Introduction by Chip Structure

3.3.1 Membrane-based Organ-on-Chip

3.3.2 Membrane-free Organ-on-Chip

3.3.3 Global Organ On Chip Sales Value by Chip Structure

3.3.3.1 Global Organ On Chip Sales Value by Chip Structure (2021 vs 2025 vs 2032)

3.3.3.2 Global Organ On Chip Sales Value, by Chip Structure (2021–2032)

3.3.3.3 Global Organ On Chip Sales Value, by Chip Structure (%), 2021–2032

4 Segmentation by End User

4.1 Introduction by End User

4.1.1 Pharmaceutical & Biotechnology Companies

4.1.2 Academic & Research Institutes

4.1.3 Cosmetics Industry

4.1.4 Others

4.2 Global Organ On Chip Sales Value by End User

4.2.1 Global Organ On Chip Sales Value by End User (2021 vs 2025 vs 2032)

4.2.2 Global Organ On Chip Sales Value by End User (2021–2032)

4.2.3 Global Organ On Chip Sales Value by End User (%), 2021–2032

5 Segmentation by Region

5.1 Global Organ On Chip Sales Value by Region

5.1.1 Global Organ On Chip Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Organ On Chip Sales Value by Region (2021–2026)

5.1.3 Global Organ On Chip Sales Value by Region (2027–2032)

5.1.4 Global Organ On Chip Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Organ On Chip Sales Value, 2021–2032

5.2.2 North America Organ On Chip Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Organ On Chip Sales Value, 2021–2032

5.3.2 Europe Organ On Chip Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Organ On Chip Sales Value, 2021–2032

5.4.2 Asia Pacific Organ On Chip Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Organ On Chip Sales Value, 2021–2032

5.5.2 South America Organ On Chip Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Organ On Chip Sales Value, 2021–2032

5.6.2 Middle East & Africa Organ On Chip Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Organ On Chip Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Organ On Chip Sales Value, 2021–2032

6.3 United States

6.3.1 United States Organ On Chip Sales Value, 2021–2032

6.3.2 United States Organ On Chip Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Organ On Chip Sales Value by End User, 2025 vs 2032

6.4 Europe

6.4.1 Europe Organ On Chip Sales Value, 2021–2032

6.4.2 Europe Organ On Chip Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Organ On Chip Sales Value by End User, 2025 vs 2032

6.5 China

6.5.1 China Organ On Chip Sales Value, 2021–2032

6.5.2 China Organ On Chip Sales Value by Type (%), 2025 vs 2032

6.5.3 China Organ On Chip Sales Value by End User, 2025 vs 2032

6.6 Japan

6.6.1 Japan Organ On Chip Sales Value, 2021–2032

6.6.2 Japan Organ On Chip Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Organ On Chip Sales Value by End User, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Organ On Chip Sales Value, 2021–2032

6.7.2 South Korea Organ On Chip Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Organ On Chip Sales Value by End User, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Organ On Chip Sales Value, 2021–2032

6.8.2 Southeast Asia Organ On Chip Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Organ On Chip Sales Value by End User, 2025 vs 2032

6.9 India

6.9.1 India Organ On Chip Sales Value, 2021–2032

6.9.2 India Organ On Chip Sales Value by Type (%), 2025 vs 2032

6.9.3 India Organ On Chip Sales Value by End User, 2025 vs 2032

7 Company Profiles

7.1 Emulate

7.1.1 Emulate Profile

7.1.2 Emulate Main Business

7.1.3 Emulate Organ On Chip Products, Services, and Solutions

7.1.4 Emulate Organ On Chip Revenue (US$ Million), 2021–2026

7.1.5 Emulate Recent Developments

7.2 MIMETAS

7.2.1 MIMETAS Profile

7.2.2 MIMETAS Main Business

7.2.3 MIMETAS Organ On Chip Products, Services, and Solutions

7.2.4 MIMETAS Organ On Chip Revenue (US$ Million), 2021–2026

7.2.5 MIMETAS Recent Developments

7.3 TissUse

7.3.1 TissUse Profile

7.3.2 TissUse Main Business

7.3.3 TissUse Organ On Chip Products, Services, and Solutions

7.3.4 TissUse Organ On Chip Revenue (US$ Million), 2021–2026

7.3.5 TissUse Recent Developments

7.4 CN Bio Innovations

7.4.1 CN Bio Innovations Profile

7.4.2 CN Bio Innovations Main Business

7.4.3 CN Bio Innovations Organ On Chip Products, Services, and Solutions

7.4.4 CN Bio Innovations Organ On Chip Revenue (US$ Million), 2021–2026

7.4.5 CN Bio Innovations Recent Developments

7.5 AIM Biotech

7.5.1 AIM Biotech Profile

7.5.2 AIM Biotech Main Business

7.5.3 AIM Biotech Organ On Chip Products, Services, and Solutions

7.5.4 AIM Biotech Organ On Chip Revenue (US$ Million), 2021–2026

7.5.5 AIM Biotech Recent Developments

7.6 AlveoliX

7.6.1 AlveoliX Profile

7.6.2 AlveoliX Main Business

7.6.3 AlveoliX Organ On Chip Products, Services, and Solutions

7.6.4 AlveoliX Organ On Chip Revenue (US$ Million), 2021–2026

7.6.5 AlveoliX Recent Developments

7.7 Beonchip

7.7.1 Beonchip Profile

7.7.2 Beonchip Main Business

7.7.3 Beonchip Organ On Chip Products, Services, and Solutions

7.7.4 Beonchip Organ On Chip Revenue (US$ Million), 2021–2026

7.7.5 Beonchip Recent Developments

7.8 React4life

7.8.1 React4life Profile

7.8.2 React4life Main Business

7.8.3 React4life Organ On Chip Products, Services, and Solutions

7.8.4 React4life Organ On Chip Revenue (US$ Million), 2021–2026

7.8.5 React4life Recent Developments

7.9 InSphero

7.9.1 InSphero Profile

7.9.2 InSphero Main Business

7.9.3 InSphero Organ On Chip Products, Services, and Solutions

7.9.4 InSphero Organ On Chip Revenue (US$ Million), 2021–2026

7.9.5 InSphero Recent Developments

7.10 NETRI

7.10.1 NETRI Profile

7.10.2 NETRI Main Business

7.10.3 NETRI Organ On Chip Products, Services, and Solutions

7.10.4 NETRI Organ On Chip Revenue (US$ Million), 2021–2026

7.10.5 NETRI Recent Developments

7.11 SynVivo

7.11.1 SynVivo Profile

7.11.2 SynVivo Main Business

7.11.3 SynVivo Organ On Chip Products, Services, and Solutions

7.11.4 SynVivo Organ On Chip Revenue (US$ Million), 2021–2026

7.11.5 SynVivo Recent Developments

7.12 BiomimX

7.12.1 BiomimX Profile

7.12.2 BiomimX Main Business

7.12.3 BiomimX Organ On Chip Products, Services, and Solutions

7.12.4 BiomimX Organ On Chip Revenue (US$ Million), 2021–2026

7.12.5 BiomimX Recent Developments

7.13 Dynamic42

7.13.1 Dynamic42 Profile

7.13.2 Dynamic42 Main Business

7.13.3 Dynamic42 Organ On Chip Products, Services, and Solutions

7.13.4 Dynamic42 Organ On Chip Revenue (US$ Million), 2021–2026

7.13.5 Dynamic42 Recent Developments

7.14 Kirkstall

7.14.1 Kirkstall Profile

7.14.2 Kirkstall Main Business

7.14.3 Kirkstall Organ On Chip Products, Services, and Solutions

7.14.4 Kirkstall Organ On Chip Revenue (US$ Million), 2021–2026

7.14.5 Kirkstall Recent Developments

7.15 Cherry Biotech

7.15.1 Cherry Biotech Profile

7.15.2 Cherry Biotech Main Business

7.15.3 Cherry Biotech Organ On Chip Products, Services, and Solutions

7.15.4 Cherry Biotech Organ On Chip Revenue (US$ Million), 2021–2026

7.15.5 Cherry Biotech Recent Developments

7.16 Micronit

7.16.1 Micronit Profile

7.16.2 Micronit Main Business

7.16.3 Micronit Organ On Chip Products, Services, and Solutions

7.16.4 Micronit Organ On Chip Revenue (US$ Million), 2021–2026

7.16.5 Micronit Recent Developments

7.17 Cellbox Labs

7.17.1 Cellbox Labs Profile

7.17.2 Cellbox Labs Main Business

7.17.3 Cellbox Labs Organ On Chip Products, Services, and Solutions

7.17.4 Cellbox Labs Organ On Chip Revenue (US$ Million), 2021–2026

7.17.5 Cellbox Labs Recent Developments

7.18 REVIVO BioSystems

7.18.1 REVIVO BioSystems Profile

7.18.2 REVIVO BioSystems Main Business

7.18.3 REVIVO BioSystems Organ On Chip Products, Services, and Solutions

7.18.4 REVIVO BioSystems Organ On Chip Revenue (US$ Million), 2021–2026

7.18.5 REVIVO BioSystems Recent Developments

7.19 MesoBioTech

7.19.1 MesoBioTech Profile

7.19.2 MesoBioTech Main Business

7.19.3 MesoBioTech Organ On Chip Products, Services, and Solutions

7.19.4 MesoBioTech Organ On Chip Revenue (US$ Million), 2021–2026

7.19.5 MesoBioTech Recent Developments

7.20 Beijing Daxiang Biotech

7.20.1 Beijing Daxiang Biotech Profile

7.20.2 Beijing Daxiang Biotech Main Business

7.20.3 Beijing Daxiang Biotech Organ On Chip Products, Services, and Solutions

7.20.4 Beijing Daxiang Biotech Organ On Chip Revenue (US$ Million), 2021–2026

7.20.5 Beijing Daxiang Biotech Recent Developments

7.21 AVATARGET

7.21.1 AVATARGET Profile

7.21.2 AVATARGET Main Business

7.21.3 AVATARGET Organ On Chip Products, Services, and Solutions

7.21.4 AVATARGET Organ On Chip Revenue (US$ Million), 2021–2026

7.21.5 AVATARGET Recent Developments

7.22 Suzhou Jiyan Biopharmaceutical

7.22.1 Suzhou Jiyan Biopharmaceutical Profile

7.22.2 Suzhou Jiyan Biopharmaceutical Main Business

7.22.3 Suzhou Jiyan Biopharmaceutical Organ On Chip Products, Services, and Solutions

7.22.4 Suzhou Jiyan Biopharmaceutical Organ On Chip Revenue (US$ Million), 2021–2026

7.22.5 Suzhou Jiyan Biopharmaceutical Recent Developments

8 Industry Chain Analysis

8.1 Organ On Chip Value Chain

8.2 Organ On Chip Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Organ On Chip Sales Model

8.5.2 Sales Channels

8.5.3 Organ On Chip Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Organ On Chip Market Trends

Table 2. Organ On Chip Market Drivers & Opportunities

Table 3. Organ On Chip Market Challenges

Table 4. Organ On Chip Market Restraints

Table 5. Global Organ On Chip Revenue by Company (US$ Million), 2021–2026

Table 6. Global Organ On Chip Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Organ On Chip Product Type

Table 9. Key Companies General Availability (GA) Timeline for Organ On Chip

Table 10. Global Organ On Chip Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Organ On Chip revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Organ On Chip Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Organ On Chip Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Organ On Chip Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Organ On Chip Sales Market Share in Value by Type (2021–2026)

Table 17. Global Organ On Chip Sales Market Share in Value by Type (2027–2032)

Table 18. Global Organ On Chip Sales Value by System Integration: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Organ On Chip Sales Value by System Integration (US$ Million), 2021–2026

Table 20. Global Organ On Chip Sales Value by System Integration (US$ Million), 2027–2032

Table 21. Global Organ On Chip Sales Market Share in Value by System Integration (2021–2026)

Table 22. Global Organ On Chip Sales Market Share in Value by System Integration (2027–2032)

Table 23. Global Organ On Chip Sales Value by Chip Structure: 2021 vs 2025 vs 2032 (US$ Million)

Table 24. Global Organ On Chip Sales Value by Chip Structure (US$ Million), 2021–2026

Table 25. Global Organ On Chip Sales Value by Chip Structure (US$ Million), 2027–2032

Table 26. Global Organ On Chip Sales Market Share in Value by Chip Structure (2021–2026)

Table 27. Global Organ On Chip Sales Market Share in Value by Chip Structure (2027–2032)

Table 28. Global Organ On Chip Sales Value by End User: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Organ On Chip Sales Value by End User (US$ Million), 2021–2026

Table 30. Global Organ On Chip Sales Value by End User (US$ Million), 2027–2032

Table 31. Global Organ On Chip Sales Market Share in Value by End User (2021–2026)

Table 32. Global Organ On Chip Sales Market Share in Value by End User (2027–2032)

Table 33. Global Organ On Chip Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 34. Global Organ On Chip Sales Value by Region (US$ Million), 2021–2026

Table 35. Global Organ On Chip Sales Value by Region (US$ Million), 2027–2032

Table 36. Global Organ On Chip Sales Value by Region (%), 2021–2026

Table 37. Global Organ On Chip Sales Value by Region (%), 2027–2032

Table 38. Key Countries/Regions Organ On Chip Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 39. Key Countries/Regions Organ On Chip Sales Value, (US$ Million), 2021–2026

Table 40. Key Countries/Regions Organ On Chip Sales Value, (US$ Million), 2027–2032

Table 41. Emulate Basic Information List

Table 42. Emulate Description and Business Overview

Table 43. Emulate Organ On Chip Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Organ On Chip Business of Emulate (2021–2026)

Table 45. Emulate Recent Developments

Table 46. MIMETAS Basic Information List

Table 47. MIMETAS Description and Business Overview

Table 48. MIMETAS Organ On Chip Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Organ On Chip Business of MIMETAS (2021–2026)

Table 50. MIMETAS Recent Developments

Table 51. TissUse Basic Information List

Table 52. TissUse Description and Business Overview

Table 53. TissUse Organ On Chip Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Organ On Chip Business of TissUse (2021–2026)

Table 55. TissUse Recent Developments

Table 56. CN Bio Innovations Basic Information List

Table 57. CN Bio Innovations Description and Business Overview

Table 58. CN Bio Innovations Organ On Chip Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Organ On Chip Business of CN Bio Innovations (2021–2026)

Table 60. CN Bio Innovations Recent Developments

Table 61. AIM Biotech Basic Information List

Table 62. AIM Biotech Description and Business Overview

Table 63. AIM Biotech Organ On Chip Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Organ On Chip Business of AIM Biotech (2021–2026)

Table 65. AIM Biotech Recent Developments

Table 66. AlveoliX Basic Information List

Table 67. AlveoliX Description and Business Overview

Table 68. AlveoliX Organ On Chip Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Organ On Chip Business of AlveoliX (2021–2026)

Table 70. AlveoliX Recent Developments

Table 71. Beonchip Basic Information List

Table 72. Beonchip Description and Business Overview

Table 73. Beonchip Organ On Chip Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Organ On Chip Business of Beonchip (2021–2026)

Table 75. Beonchip Recent Developments

Table 76. React4life Basic Information List

Table 77. React4life Description and Business Overview

Table 78. React4life Organ On Chip Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Organ On Chip Business of React4life (2021–2026)

Table 80. React4life Recent Developments

Table 81. InSphero Basic Information List

Table 82. InSphero Description and Business Overview

Table 83. InSphero Organ On Chip Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Organ On Chip Business of InSphero (2021–2026)

Table 85. InSphero Recent Developments

Table 86. NETRI Basic Information List

Table 87. NETRI Description and Business Overview

Table 88. NETRI Organ On Chip Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Organ On Chip Business of NETRI (2021–2026)

Table 90. NETRI Recent Developments

Table 91. SynVivo Basic Information List

Table 92. SynVivo Description and Business Overview

Table 93. SynVivo Organ On Chip Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Organ On Chip Business of SynVivo (2021–2026)

Table 95. SynVivo Recent Developments

Table 96. BiomimX Basic Information List

Table 97. BiomimX Description and Business Overview

Table 98. BiomimX Organ On Chip Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Organ On Chip Business of BiomimX (2021–2026)

Table 100. BiomimX Recent Developments

Table 101. Dynamic42 Basic Information List

Table 102. Dynamic42 Description and Business Overview

Table 103. Dynamic42 Organ On Chip Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Organ On Chip Business of Dynamic42 (2021–2026)

Table 105. Dynamic42 Recent Developments

Table 106. Kirkstall Basic Information List

Table 107. Kirkstall Description and Business Overview

Table 108. Kirkstall Organ On Chip Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Organ On Chip Business of Kirkstall (2021–2026)

Table 110. Kirkstall Recent Developments

Table 111. Cherry Biotech Basic Information List

Table 112. Cherry Biotech Description and Business Overview

Table 113. Cherry Biotech Organ On Chip Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Organ On Chip Business of Cherry Biotech (2021–2026)

Table 115. Cherry Biotech Recent Developments

Table 116. Micronit Basic Information List

Table 117. Micronit Description and Business Overview

Table 118. Micronit Organ On Chip Products, Services, and Solutions

Table 119. Revenue (US$ Million) in Organ On Chip Business of Micronit (2021–2026)

Table 120. Micronit Recent Developments

Table 121. Cellbox Labs Basic Information List

Table 122. Cellbox Labs Description and Business Overview

Table 123. Cellbox Labs Organ On Chip Products, Services, and Solutions

Table 124. Revenue (US$ Million) in Organ On Chip Business of Cellbox Labs (2021–2026)

Table 125. Cellbox Labs Recent Developments

Table 126. REVIVO BioSystems Basic Information List

Table 127. REVIVO BioSystems Description and Business Overview

Table 128. REVIVO BioSystems Organ On Chip Products, Services, and Solutions

Table 129. Revenue (US$ Million) in Organ On Chip Business of REVIVO BioSystems (2021–2026)

Table 130. REVIVO BioSystems Recent Developments

Table 131. MesoBioTech Basic Information List

Table 132. MesoBioTech Description and Business Overview

Table 133. MesoBioTech Organ On Chip Products, Services, and Solutions

Table 134. Revenue (US$ Million) in Organ On Chip Business of MesoBioTech (2021–2026)

Table 135. MesoBioTech Recent Developments

Table 136. Beijing Daxiang Biotech Basic Information List

Table 137. Beijing Daxiang Biotech Description and Business Overview

Table 138. Beijing Daxiang Biotech Organ On Chip Products, Services, and Solutions

Table 139. Revenue (US$ Million) in Organ On Chip Business of Beijing Daxiang Biotech (2021–2026)

Table 140. Beijing Daxiang Biotech Recent Developments

Table 141. AVATARGET Basic Information List

Table 142. AVATARGET Description and Business Overview

Table 143. AVATARGET Organ On Chip Products, Services, and Solutions

Table 144. Revenue (US$ Million) in Organ On Chip Business of AVATARGET (2021–2026)

Table 145. AVATARGET Recent Developments

Table 146. Suzhou Jiyan Biopharmaceutical Basic Information List

Table 147. Suzhou Jiyan Biopharmaceutical Description and Business Overview

Table 148. Suzhou Jiyan Biopharmaceutical Organ On Chip Products, Services, and Solutions

Table 149. Revenue (US$ Million) in Organ On Chip Business of Suzhou Jiyan Biopharmaceutical (2021–2026)

Table 150. Suzhou Jiyan Biopharmaceutical Recent Developments

Table 151. Revenue (US$ Million) in Organ On Chip Business of Company 40 (2021–2026)

Table 152. Company 40 Recent Developments

Table 153. Key Raw Materials Lists

Table 154. Key Suppliers of Raw Materials Lists

Table 155. Organ On Chip Downstream Customers

Table 156. Organ On Chip Distributors List

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Organ On Chip Product Picture

Figure 2. Global Organ On Chip Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 4. Organ On Chip Report Years Considered

Figure 5. Global Organ On Chip Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Organ On Chip Revenue in 2025

Figure 7. Organ On Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Brain-on-a-chip Picture

Figure 9. Liver-on-a-chip Picture

Figure 10. Kidney-on-a-chip Picture

Figure 11. Lung-on-a-chip Picture

Figure 12. Heart-on-a-chip Picture

Figure 13. Intestine-on-a-chip Picture

Figure 14. Vessel-on-a-chip Picture

Figure 15. Other Organs Picture

Figure 16. Global Organ On Chip Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Organ On Chip Sales Value Market Share by Type, 2025 & 2032

Figure 18. Single-organ-on-Chip Picture

Figure 19. Multi-organ-on-Chip Picture

Figure 20. Global Organ On Chip Sales Value by System Integration (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Organ On Chip Sales Value Market Share by System Integration, 2025 & 2032

Figure 22. Membrane-based Organ-on-Chip Picture

Figure 23. Membrane-free Organ-on-Chip Picture

Figure 24. Global Organ On Chip Sales Value by Chip Structure (US$ Million), 2021 vs 2025 vs 2032

Figure 25. Global Organ On Chip Sales Value Market Share by Chip Structure, 2025 & 2032

Figure 26. Product Picture of Pharmaceutical & Biotechnology Companies

Figure 27. Product Picture of Academic & Research Institutes

Figure 28. Product Picture of Cosmetics Industry

Figure 29. Product Picture of Others

Figure 30. Global Organ On Chip Sales Value by End User (US$ Million), 2021 vs 2025 vs 2032

Figure 31. Global Organ On Chip Sales Value Market Share by End User, 2025 & 2032

Figure 32. North America Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 33. North America Organ On Chip Sales Value by Country (%), 2025 vs 2032

Figure 34. Europe Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 35. Europe Organ On Chip Sales Value by Country (%), 2025 vs 2032

Figure 36. Asia Pacific Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 37. Asia Pacific Organ On Chip Sales Value by Subregion (%), 2025 vs 2032

Figure 38. South America Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 39. South America Organ On Chip Sales Value by Country (%), 2025 vs 2032

Figure 40. Middle East & Africa Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 41. Middle East & Africa Organ On Chip Sales Value by Country (%), 2025 vs 2032

Figure 42. Key Countries/Regions Organ On Chip Sales Value (%), 2021–2032

Figure 43. United States Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 44. United States Organ On Chip Sales Value by Type (%), 2025 vs 2032

Figure 45. United States Organ On Chip Sales Value by End User (%), 2025 vs 2032

Figure 46. Europe Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 47. Europe Organ On Chip Sales Value by Type (%), 2025 vs 2032

Figure 48. Europe Organ On Chip Sales Value by End User (%), 2025 vs 2032

Figure 49. China Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 50. China Organ On Chip Sales Value by Type (%), 2025 vs 2032

Figure 51. China Organ On Chip Sales Value by End User (%), 2025 vs 2032

Figure 52. Japan Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 53. Japan Organ On Chip Sales Value by Type (%), 2025 vs 2032

Figure 54. Japan Organ On Chip Sales Value by End User (%), 2025 vs 2032

Figure 55. South Korea Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 56. South Korea Organ On Chip Sales Value by Type (%), 2025 vs 2032

Figure 57. South Korea Organ On Chip Sales Value by End User (%), 2025 vs 2032

Figure 58. Southeast Asia Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 59. Southeast Asia Organ On Chip Sales Value by Type (%), 2025 vs 2032

Figure 60. Southeast Asia Organ On Chip Sales Value by End User (%), 2025 vs 2032

Figure 61. India Organ On Chip Sales Value (US$ Million), 2021–2032

Figure 62. India Organ On Chip Sales Value by Type (%), 2025 vs 2032

Figure 63. India Organ On Chip Sales Value by End User (%), 2025 vs 2032

Figure 64. Organ On Chip Value Chain

Figure 65. Organ On Chip Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Organ On Chip in 2026? zhanKai

The global market size of Organ On Chip in 2026 was 281 Million USD.

Which companies rank high in the global Organ On Chip market? shouQi

What was the global market size of Organ On Chip in 2032? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Organ On Chip market size from 2026 to 2032? shouQi

Related Reports

Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Organ On Chip market is projected to grow from US$ 221 million in 2025 to US$ 1368 million by 2032, at a CAGR of 30.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-15
Pages: 174
USD 4900.00
(Single User License)
Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Organ On Chip market size was US$ 221 million in 2025 and is forecast to reach a readjusted size of US$ 1368 million by 2032 with a CAGR of 30.2% during the forecast period 2026-2032.
Published Date: 2026-08-15
Pages: 141
USD 4250.00
(Single User License)
Global Organ On Chip Market Research Report 2026
The global Organ On Chip market was valued at US$ 221 million in 2025 and is anticipated to reach US$ 1368 million by 2032, at a CAGR of 30.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 160
USD 2900.00
(Single User License)
Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published Date: 2025-10-16
Pages: 152
USD 3950.00
(Single User License)
Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Organ On Chip market size was US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published Date: 2025-09-08
Pages: 115
USD 4250.00
(Single User License)
Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Organ On Chip market is projected to grow from US$ 166 million in 2024 to US$ 1076 million by 2031, at a CAGR of 30.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-08
Pages: 172
USD 4900.00
(Single User License)
Global Organ On Chip Market Research Report 2025
The global market for Organ On Chip was valued at US$ 166 million in the year 2024 and is projected to reach a revised size of US$ 1076 million by 2031, growing at a CAGR of 30.2% during the forecast period.
Published Date: 2025-09-08
Pages: 107
USD 2900.00
(Single User License)
Global Organ On Chip Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Organ On Chip was estimated to be worth US$ 156 million and is forecast to reach approximately US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 155
USD 5900.00
(Single User License)
Organ On Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 156 million in 2024 and is forecast to a readjusted size of US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 127
USD 3950.00
(Single User License)
Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Published Date: 2024-01-06
Pages: 131
USD 3950.00
(Single User License)

Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Organ On Chip market is projected to grow from US$ 221 million in 2025 to US$ 1368 million by 2032, at a CAGR of 30.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-15
Pages: 174
USD 4900.00 (Single User License)
Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Organ On Chip market size was US$ 221 million in 2025 and is forecast to reach a readjusted size of US$ 1368 million by 2032 with a CAGR of 30.2% during the forecast period 2026-2032.
Published: 2026-08-15
Pages: 141
USD 4250.00 (Single User License)
Global Organ On Chip Market Research Report 2026
The global Organ On Chip market was valued at US$ 221 million in 2025 and is anticipated to reach US$ 1368 million by 2032, at a CAGR of 30.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 160
USD 2900.00 (Single User License)
Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published: 2025-10-16
Pages: 152
USD 3950.00 (Single User License)
Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Organ On Chip market size was US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published: 2025-09-08
Pages: 115
USD 4250.00 (Single User License)
Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Organ On Chip market is projected to grow from US$ 166 million in 2024 to US$ 1076 million by 2031, at a CAGR of 30.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-08
Pages: 172
USD 4900.00 (Single User License)
Global Organ On Chip Market Research Report 2025
The global market for Organ On Chip was valued at US$ 166 million in the year 2024 and is projected to reach a revised size of US$ 1076 million by 2031, growing at a CAGR of 30.2% during the forecast period.
Published: 2025-09-08
Pages: 107
USD 2900.00 (Single User License)
Global Organ On Chip Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Organ On Chip was estimated to be worth US$ 156 million and is forecast to reach approximately US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 155
USD 5900.00 (Single User License)
Organ On Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 156 million in 2024 and is forecast to a readjusted size of US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 127
USD 3950.00 (Single User License)
Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Published: 2024-01-06
Pages: 131
USD 3950.00 (Single User License)